---
title: Skin and soft tissue infection
creation date: 2024-08-09 16:06
status: finished
tags:
  - teaching
  - medicine/SSTI
share_link: https://share.note.sx/m28oc93u#wJdC3rLRCv5lXc6KgORO5De/g0L80wqZBMz6mnLkls8
share_updated: 2024-08-14T16:03:50+08:00
share: true
category: medicine
alias: ssti
---
# Skin and soft tissue infection  
source: Pocket Medicine, 2022  
## 定義  
  
- 蜂窩性組織炎：是真皮和皮下組織的感染，特徵為紅斑、發熱、壓痛和腫脹；通常因皮膚破損引起（JAMA 2016;315:3）。  
- 皮膚膿瘍：皮下膿液的聚集。  
- 葡萄球菌中毒性休克症候群（Staphylococcal toxic shock syndrome）：快速發作的發燒、皮疹、低血壓和多重器官損傷。診斷不需要葡萄球菌的培養。通常與填充物（如衛生棉條、鼻腔填充物）有關。處理可能需要手術清創加上抗生素治療。  
  
## 風險因素  
  
- 創傷、水腫、先前的皮膚炎症或感染、肥胖、糖尿病、其他免疫抑制情況（CID 2014;59:e10）。  
  
## 微生物學  
  
- 化膿性：MRSA（NEJM 2006;355:666）引起多達75%的化膿性皮膚/軟組織感染，其次是MSSA和鏈球菌。  
- 非化膿性：**鏈球菌**、MSSA、需氧革蘭氏陰性桿菌。MRSA較不常見，除非有顯著風險因素（如先前MRSA感染、靜脈注射藥物使用者、血液透析、近期使用抗生素或住院）。  
- 咬傷：皮膚（鏈球菌、葡萄球菌 [僅在有風險因素時考慮MRSA]）和口腔菌群（包括厭氧菌）加上特殊暴露：  
  
| **特徵**    | **微生物學**                        | **臨床表現**                               | **治療**                                             |  
| --------- | ------------------------------- | -------------------------------------- | -------------------------------------------------- |  
| 貓咬傷^      | Pasturella spp                  | 快速出現紅斑、腫脹、淋巴管炎、發燒                      | Amox/clav                                          |  
| 狗咬傷       | Pasturella & Capnocytophaga spp | 在無脾患者/肝硬化患者和其他免疫抑制患者中可引起嚴重敗血症，伴隨DIC和壞疽 | Amox/clav<br><br>如懷疑感染Capno.：使用pip/tazo或carbapenem |  
| 穿透性損傷     | Pseudomonas                     | 可能與深部組織膿瘍有關                            | 根據敏感性選擇治療方案                                        |  
| 園藝活動      | Sporothrix                      | 潰瘍性結節，延淋巴擴散                            | Itraconazole                                       |  
| 鹽水或生蠔/魚暴露 | V. vulnificus                   | 出血性水疱及敗血症（尤其在肝硬化患者中）                   | Doxy + Ceftazidime/ceftriaxone                     |  
|           | Mycobacterium marinum           | 緩慢進展，四肢結節/淺表淋巴結炎                       | Macrolide+rifampin/ethambutol                      |  
| 淡水暴露      | Aeromonas                       | 可導致肌壞死/橫紋肌溶解                           | FQ, TMP-SMX, 或 ceftriaxone                         |  
^貓抓病由Bartonella通過貓抓或咬傷引起。導致淋巴結炎。  
  
## 診斷  
  
- 根據理學檢查進行臨床診斷  
- 不應從完整皮膚上進行培養，因為沒有幫助（CID 2014;59:e10）  
- 血液培養通常陽性率很低（約5-10%）  
- 超音波檢查可用於識別深部膿瘍並幫助引流。如果發現膿瘍，切開引流是治療的關鍵。  
- 膿瘍抽取物可能提供微生物學診斷  
  
## 治療（_NEJM_ 2014;370:2238; _CID_ 2014;59:e10; _JAMA_ 2016;316:325 & 2017;317:2088）  
  
| **是否化膿性** | **常見的微生物**                   | **嚴重程度** | **治療**                                                     |  
| --------- | ---------------------------- | -------- | ---------------------------------------------------------- |  
| 否         | β-溶血性鏈球菌 > S. aureus         | 輕度       | 口服：penicillin VK、cephalosporin                             |  
|           |                              | 中度       | 靜脈注射：penicillin、ceftriaxone、cefazolin                      |  
|           |                              | 重度       | 靜脈注射：vanc + pip/tazo（± clinda if TSS）                      |  
| 是         | S. aureus（包括MRSA）>> β-溶血性鏈球菌 | 輕度       | I&D only 或 I&D + clinda or TMP-SMX（_NEJM_ 2017;376:2545）   |  
|           |                              | 中度       | I&D + TMP-SMX or doxycycline                               |  
|           |                              | 重度       | I&D + 靜脈注射vancomycin、daptomycin或linezolid（± clinda if TSS） |  
  
輕度：膿瘍小於2公分，無全身性感染症狀，免疫功能正常，無植入物；中度：全身性症狀；重度：SIRS或免疫抑制  
  
- 抬高患肢；開始使用抗生素後紅斑可能加重，因為細菌殺死後會導致發炎  
- 在肥胖患者中，為避免治療失敗，應確保足夠的藥物劑量（J Infect 2012;2:128）  
- 治療持續時間：根據嚴重程度和治療反應，從5天到最多14天。拍照並畫出邊界以追蹤進展  
  
# 壞死性軟組織感染（NEJM 2017;377:2253）  
  
## 定義  
  
* 猛爆性組織破壞、全身性毒性和高死亡率。屬於外科急症  
* 可能包括蜂窩性組織炎、筋膜炎、肌炎、肌壞死（產氣性壞疽）  
  
## 風險因素  
- 通常通過皮膚/黏膜損傷或創傷性傷口影響健康人，但糖尿病、周邊血管疾病、酗酒、靜脈注射藥物使用者、肝硬化或其他免疫抑制者風險增加  
  
## 微生物學  
### 壞死性筋膜炎  
  
- 第一型：多重病原菌（混合嗜氧菌和厭氧菌），通常發生於具有上述風險因素的老年患者  
	- Fournier氏壞疽影響生殖器和/或會陰部  
	- 頭頸部壞死性軟組織感染由口腔菌群（包括厭氧菌）引起  
- 第二型：單一病原菌，通常為A群鏈球菌，較少見的是*S. aureus*、*Vibrio*、*Aeromonas*；與TSS相關  
- Clostridial myonecrosis（氣性壞疽）：由*C. perfringens*或*C. septicum*引起，革蘭氏染色顯示大革蘭氏陽性桿菌，端部鈍圓。與創傷性傷口相關，這些創傷性傷口創造了適合梭狀芽孢桿菌生長的厭氧環境  
  
## 臨床表現  
- 紅斑、水腫、發熱加上全身性症狀，可能伴隨有捻髮感、水疱、壞死。  
- 臨床症狀迅速惡化  
- 疼痛程度超過明顯的蜂窩性組織炎；皮膚先出現感覺過敏，後來則感覺喪失  
  
## 診斷  
- 臨床診斷足以開始緊急手術探查  
- 壞死中心的抽吸物；血液培養；革蘭氏染色；乳酸、AST和CK以檢查深部組織壞死  
- 影像學檢查：**無顯影劑**的CT檢查，但不應延遲治療/手術（Arch Surg 2010;145:452）  
- 手術檢體的革蘭氏染色和培養可進行微生物學診斷  
  
## 治療（CID 2014;60:169）  
  
- 緊急手術探查和壞死組織的清創，並諮詢感染科  
- 經驗性抗生素： [pip/tazo or (ceftriaxone + metronidazole) or carbapenem] + [vancomycin或linezolid]。  
- A群鏈球菌：penicillin + clindamycin，並考慮使用IVIG治療中毒性休克  
  
# 糖尿病足部感染  
  
## 微生物學與嚴重程度 (CID 2004;39:885)  
- 輕度（表淺性潰瘍，無深層結構受累，周圍紅斑 <2公分，且無全身性症狀）：通常為*S. aureus*或嗜氧性鏈球菌  
- 中度（潰瘍伴有深層結構受累，周圍紅斑 **>2公分**，或淋巴管發炎性條紋且無全身性症狀）：更可能為慢性及多重微生物感染（Pseudomonas aeruginosa、腸球菌、腸道革蘭氏陰性桿菌、厭氧菌）  
- 嚴重（中度 + 全身性症狀或代謝不穩定）：厭氧性鏈球菌、腸道革蘭氏陰性桿菌、Pseudomonas aeruginosa、Bacteroides、Clostridium  
  
## 初步評估  
- 清創、去除壞死組織、探查並取得深部厭氧菌及嗜氧菌培養  
- 評估周邊血管疾病：感覺、脈搏、踝臂指數（ABI）  
  
## 診斷  
  
- 清創時取深層組織培養（理想情況下在使用抗生素前）。表面拭子通常用途有限，多為移生菌。  
- 中度/嚴重感染：取得血液培養、紅血球沉降率（ESR）、C反應蛋白（CRP）  
- 應排除骨髓炎。如果有以下情況風險較高：骨骼明顯可見或可探查到骨骼、**潰瘍 >2 公分、潰瘍持續時間 >1-2 週、ESR >70**。如果懷疑骨髓炎，應取得X光或核磁共振影像（見下方骨髓炎部分）。  
  
## 治療 (CID 2012;54:e132)  
  
- 輕度感染：口服抗生素。針對革蘭氏陽性菌（dicloxacillin、cephalexin 或 amox/clav）；使用 TMP-SMX 或 doxy 對付 MRSA。  
- 中度/嚴重感染：靜脈注射抗生素。針對革蘭氏陽性菌（vancomycin、linezolid、daptomycin） + 革蘭氏陰性菌（ceftriaxone、levofloxacin 或 amp/sulb）± 厭氧菌（metronidazole 或 clindamycin）。如果有以下情況，增加抗*Pseudomonas aeruginosa*抗生素（cefepime 或 pip/tazo）：浸軟傷口、顯著水域暴露、溫暖氣候  
- 抬高患肢，避免負重，傷口護理，控制血糖，治療靜脈功能不全和動脈缺血  
- 許多需要手術：早期、積極且重複的清創；可能需要血管重建或截肢  
  
# 骨髓炎  
  
- 骨骼感染，可能是由血源性感染或直接從鄰近部位擴散  
  
## 病因 (Lancet 2004;364:369)  
- 血源性感染：***S. aureus***；脊椎體結核感染 = Pott 病  
- 鄰近部位感染（可能是急性或慢性）  
  - 開放性骨折、骨科手術等：***S. aureus*** 和 **S. epidermidis (coagulase-negative Staphylococcus)**  
  - 皮膚破損 + 血管功能不全（例如糖尿病足、壓瘡）：多重微生物感染  
  - 泌尿系統源（革蘭氏陰性桿菌、腸球菌）  
  
## 臨床表現  
- 周圍軟組織受損 ± 瘻管至表面皮膚  
- ± 發燒、倦怠和夜間盜汗（血源性感染較常見）  
- 脊椎骨髓炎（尤其是靜脈注射毒品者）：持續性局部背痛，± 發燒（NEJM 2010;362:1022）  
  
## 診斷 (JAMA 2008;299:806)  
  
- 確保取得病原體培養數據，以避免長期使用經驗性抗生素  
- 骨組織切片或組織培養，透過手術或經皮切片獲得（送嗜氧菌、厭氧菌、結核菌和真菌培養 + 病理檢查），除非血液培養結果為陽性。不要依賴潰瘍或瘻管引流的拭子。  
- 理學檢查：如果在糖尿病足（見上方）中能**探查潰瘍至骨骼**或**潰瘍 >2 cm²**，則高度懷疑（靈敏度 83%，特異度 90%）  
- 使用抗生素前進行血液培養（急性血源性骨髓炎更常陽性）  
- CBC、CRP、ESR（==**>70**== 大幅增加骨髓炎的可能性）  
- 影像學檢查  
  - 普通 X 光片：早期疾病正常；2-6 週後可見溶骨性病變  
  - 磁共振影像（MRI）：首選影像學檢查（整體靈敏度 90%，特異度 82%；Archives 2007;167:125）  
  - CT：可以顯示骨膜反應及皮質和骨髓破壞  
  - CT 和 MRI 雖靈敏度高但特異度低；如果是鄰近焦點伴骨膜反應或 Charcot 改變，可能會偽陽性  
  - 核醫影像：靈敏度高但特異度低（如果有軟組織發炎可能偽陽性）  
  
## 治療  
  
- 抗生素：根據培養數據。如果臨床穩定，考慮在取得骨切片結果前暫時停止使用抗生素。治療期間取決於治療策略/治療目標（例如，脊椎骨髓炎 6 週；Lancet 2015;385:875）。在靜脈抗生素或手術後 ≥7 天，如果情況良好，考慮（在與感染科醫師商討後）將靜脈改為口服（如果口服抗生素有良好的生物利用度和骨髓穿透能力）（NEJM 2019;380:425）。  
- 對於以下任何情況，應考慮手術：急性骨髓炎對醫療治療無效、慢性骨髓炎、化膿性脊椎骨髓炎的併發症（例如神經功能損害、脊椎不穩定、硬膜外膿腫）或感染的人工植入物  
  
# SKIN AND SOFT TISSUE INFECTIONS  
## Definitions  
  
- Cellulitis: infection of dermis and subcutaneous tissue characterized by erythema, warmth, tenderness, and swelling; often occurs as a result of skin breaches (JAMA 2016;315:3)  
- Skin abscess: subcutaneous collection of pus  
- Staph toxic shock syndrome: rapid onset fever, rash, hypotension, and multiorgan injury. Staph aureus culture are not necessary for diagnosis. Often associated with packing (tampon, nasal packing). Management may require surgical debridement + antibiotics  
  
## Risk Factors  
  
- Trauma, edema, preceding skin inflammation or infection, obesity, DM, other immunosupp.  (CID 2014;59:e10)  
  
## Microbiology  
  
- Purulent: MRSA (NEJM 2006;355:666) causes up to 75% of purulent skin/soft tissue infections, followed by MSSA and strep  
- Non-purulent: Strep, MSSA, aerobic GNRs. MRSA less commonly unless significant risk factors (prior MRSA infection, IVDU, HD, recent abx or hospitalization).  
- Bites: skin (Strep , Staph [MRSA only if risk factors]) and oral flora (including anaerobes) + special exposures:  
  
| **Feature**                  | **Microbiology**                  | **Clinical**                                                                             | **Treatment**                                                |  
| ---------------------------- | --------------------------------- | ---------------------------------------------------------------------------------------- | ------------------------------------------------------------ |  
| Cat bit^                     | _Pasturella spp_                  | Rapid onset erythema, swelling, lymphangitis, fever                                      | Amox/clav                                                    |  
| Dog bite                     | _Pasturella & Capnocytophaga spp_ | Can cause severe sepsis with DIC & gangrene in asplenic/cirrhotics and other immunosupp. | Amox/clav<br><br>If Capno. suspected: pip/tazo or carbapenem |  
| Penetrating injury           | _Pseudomonas_                     | Can be associated with deep tissue abscess                                               | Directed based on suscept.                                   |  
| Gardening                    | _Sporothrix_                      | Ulcerating nodules, lymphatic spread                                                     | Itraconazole                                                 |  
| Salt H2O or raw oysters/fish | _V. vulnificus_                   | Hemorrhagic bullae & sepsis (esp. in cirrhotics)                                         | Doxy + Ceftazidime/ceftriaxone                               |  
|                              | _Mycobacterium marinum_           | Indolent, nodules on extremities/superficial lymphadenitis                               | Macrolide + rifampin/ethambutol                              |  
| Fresh H2O                    | _Aeromonas_                       | Myonecrosis/rhabdo can occur.                                                            | FQ, TMP-SMX, or ceftriaxone                                  |  
^Cat scratch disease caused by _Bartonella_ acquired via cat scratch or bite. Results in lymphadenitis.  
  
## Diagnosis  
  
- Clinical diagnosis based on physical examination  
- Cultures from intact skin are not helpful and should not be performed (CID 2014;59:e10)  
- Blood culture are typically low yield (˜5-10%)  
- Ultrasound can be used to identify deep abscesses and facilitate drainage. If abscess is found, incision/drainage is key to treatment.  
- Aspirate from an abscess may provide microbiologic diagnosis  
  
## Cellulitis Treatment (_NEJM_ 2014;370:2238; _CID_ 2014;59:e10; _JAMA_ 2016;316:325 & 2017;317:2088)  
  
| **Purulent** | **Usual Microbiology**                          | **Severity** | **Treatment**                                                              |  
| ------------ | ----------------------------------------------- | ------------ | -------------------------------------------------------------------------- |  
| No           | β-hemolytic _Strep_ >_S. aureus_                | Mild         | Oral: penicillin VK, cephalosporin                                         |  
|              |                                                 | Mod          | IV: penicillin, ceftriaxone, cefazolin                                     |  
|              |                                                 | Severe       | IV: vanc + pip/tazo (± clinda for toxic shock syndrome)                    |  
| Yes          | _S. aureus_ (incl. MRSA) >> β-hemolytic _Strep_ | Mild         | Consider I&D only vs. I&D + clinda or TMP-SMX (_NEJM_ 2017;376:2545)       |  
|              |                                                 | Mod          | I&D + TMP-SMX or doxycycline                                               |  
|              |                                                 | Severe       | I&D + IV vanc, daptomycin or linezolid (± clinda for toxic shock syndrome) |  
Mild: abscess <2 cm, no systemic signs of infection, immunocompetent, no indwelling hardware; moderate: systemic signs; severe: SIRS or immunosuppressed  
  
- Limb elevation; erythema may worsen after starting abx b/c bacterial killing → inflam.  
- In obese Pts, adequate drug dosing important to avoid treatment failure (J Infect 2012;2:128)  
- Duration: 5 to up to 14 d based on severity and response to treatment. Take pictures & draw margins to track progress.  
  
# NECROTIZING SOFT-TISSUE INFECTIONS (NEJM 2017;377:2253)  
  
## Definition  
  
* Fulminant tissue destruction, systemic toxicity & high mortality. Surgical emergency.  
* May include cellulitis, fasciitis, myositis, myonecrosis (gas gangrene).  
  
## Risk factors  
- Can affect healthy individuals via skin/mucosal breach or traumatic wound, but ↑ risk w/ DM, PVD, alcohol abuse, IVDU, cirrhosis, or other immunosupp.  
  
## Microbiology  
### Necrotizing fasciitis  
  
- Type I: polymicrobial (mixed aerobes & anaerobes), typically in older Pts w/ above RFs.  
	- Fournier's gangrene involves genitalia and/or perineum  
	- Head and neck NSTI evolve from oral flora including anaerobes  
- Type II: monomicrobial, usually group A strep, less likely Staph, Vibrio, Aero.; a/w TSS  
- Clostridial myonecrosis (gas gangrene): C. perfringens; C. septicum (large Gram ⊕ rods w/ blunt ends on Gram stain). A/w traumatic wounds that create an anaerobic environment ideal for Clostridia.  
  
## Clinical manifestations  
- Erythema, edema, warmth + systemic illness ± crepitus, bullae, necrosis  
- Rapid progression of clinical signs  
- Pain out of proportion to apparent cellulitis; skin hyperesthetic and later anesthetic  
  
## Diagnosis  
- Clinical diagnosis is sufficient to initiate urgent surgical exploration  
- Aspiration of necrotic center; blood culture; Gram stain; lactate, AST, & CK for deep tissue necrosis  
- Imaging: noncontrast CT, but do not delay Rx/surgery (Arch Surg 2010;145:452)  
- Microbiologic diagnosis from Gram stain and culture of surgical specimens  
  
## Treatment (CID 2014;60:169)  
  
- Urgent surgical exploration with debridement of necrotic tissue and ID consultation  
- Empiric antibiotics: [pip/tazo or ceftriaxone + metronidazole or carbapenem] + [vanco or linezolid]. For Group A Strep: penicillin + clindamycin + consideration of IVIG for toxic shock.  
  
# DIABETIC FOOT INFECTIONS  
  
## Microbiology and severity (CID 2004;39:885)  
- Mild (superficial ulcer, no involvement of deeper structures, surrounding erythema <2 cm, and no systemic illness): usually S. aureus or aerobic streptococci  
- Moderate (ulcer with involvement of deeper structures, surrounding erythema >2 cm, or lymphangitic streaking and no systemic illness): more likely to be chronic and polymicrobial (PsA, enterococci, enteric GNR , anaerobes)  
- Severe (moderate + systemic illness or metabolic instability): anaerobic streptococci, enteric GNR, PsA, Bacteroides, Clostridium  
  
## Initial evaluation  
- Cleanse, debride, probe, and obtain deep anaerobic + aerobic cultures  
- Assess for peripheral vascular disease: sensation, pulses, ABIs  
  
## Diagnosis  
  
- Deep tissue wound culture at time of debridement (ideally prior to antibiotics). Superficial swabs are typically of limited utility due to colonization.  
- For mod/severe: obtain blood cx, ESR, CRP  
- Osteomyelitis should always be ruled out. At ↑ risk if: grossly visible bone or able to probe to bone, ulcer >2 cm, ulcer duration >1-2 wk, ESR >70. If suspicious for osteo, obtain plain films ± MRI (see osteomyelitis below).  
  
## Treatment (CID 2012;54:e132)  
  
- Mild infxn: oral abx. Target GPCs (diclox, cephalexin, or amox/clav); use TMP-SMX or doxy for MRSA.  
- Mod/severe infxn: IV abx. Target GPCs (vanco, linezolid,dapto) + GNRs (CTX, levo, or amp/sulb) ± anaerobes (metronidazole or clinda). Add PsA coverage (cefepime or piptazo) if: macerated wound, significant water exposure, warm climate  
- Elevation, non-weight-bearing status, wound care, glycemic control, Rx for venous insufficiency and arterial ischemia  
- Many require surgery: early, aggressive, and repeated debridement; revascularization or amputation may be necessary  
  
# OSTEOMYELITIS  
  
- Infection of bone due to hematogenous seeding or direct spread from contiguous focus  
  
## Etiology (Lancet 2004;364:369)  
- Hematogenous: ***S. aureus***; mycobacterial infection of vertebral body = Pott's disease  
- Contiguous focus (may be acute or chronic)  
	- Open fracture, orthopedic surgery, etc.: ***S. aureus*** and ***S. epi***  
	- Skin breakdown + vasc. insuffic. (eg, diabetic foot, pressure ulcer): polymicrobial  
	- GU source (GNR, Enterococcus)  
  
## Clinical manifestations  
- Surrounding soft-tissue compromise ± fistula to superficial skin  
- ± Fever, malaise, and night sweats (more common in hematogenous than contiguous)  
- Vertebral osteomyelitis (esp. IVDU): unremitting, focal back pain, ± fever (NEJM 2010;362:1022)  
  
## Diagnosis (JAMA 2008;299:806)  
  
- Crucial to obtain culture data of causative organism to avoid long-term empiric abx  
- Bone biopsy or tissue culture obtained surgically or via percutaneous biopsy (send aerobic, anaerobic, mycobacterial, and fungal cultures + pathology) unless ⊕ blood cx. Do not rely on swabs of ulcers or fistulae drainage.  
- Physical exam: high suspicion in diabetic foot (see above) if can **probe ulcer to bone** or **ulcer >2 cm<sup>2</sup>** (Sp 83%, 90% PPV)  
- Blood cultures before antibiotics (more often ⊕ w/ acute hematogenous osteomyelitis)  
- CBC, CRP, ESR (==**>70**== greatly ↑ likelihood of osteo)  
- Imaging  
	- Plain radiographs: normal early in disease; lytic lesions seen after 2-6 wk  
	- MRI: preferred imaging study (overall Se 90%, Sp 82%; Archives 2007;167:125)  
	- CT: can demonstrate periosteal reaction and cortical and medullary destruction  
	- CT & MRI very Se but ↓ Sp; false ⊕ if contig focus w/ periosteal reaction, Charcot Δs  
	- Radionuclide imaging: very Se but non-Sp (false ⊕ if soft-tissue inflammation)  
  
## Treatment  
  
- Antibiotics: based on culture data. If clinically stable, consider holding antibiotics until bone bx obtained. Duration depends on Rx strategy/goals of Rx management (eg, 6 wks for vertebral osteo; Lancet 2015;385:875). After ≥7 days from either start of IV abx or surgery, if doing well consider (in consultation with ID!) Δ'ing IV to PO (if good bioavailability and bone penetration) (NEJM 2019;380:425).  
- Surgery should be considered for any of the following: acute osteo that fails to respond to medical Rx, chronic osteo, complications of pyogenic vertebral osteo (eg, neurologic compromise, spinal instability, epidural abscess) or infected prosthesis  
  
# EPIDURAL ABSCESS  
  
## Etiology  
- Hematogenous spread (⅔): skin infection, soft tissue (dental abscess), or endocarditis  
- Direct extension (⅓): vertebral osteo, sacral ulcer, spinal anesthesia or surgery, LP  
- Risk factors: IVDU diabetes, renal failure, alcoholism, immunosuppression  
- *S. aureus* most common pathogen; in immunosuppressed, consider fungal, TB, and Nocardia  
  
## Clinical manifestations  
- Back pain with spinal or paraspinal tenderness + fever ± followed by radiculopathy. Sx of cord compression or cauda equina is a surgical emergency.  
  
## Diagnostic studies  
- MRI with contrast  
- Aspiration of abscess fluid for Gram stain & culture or operative Gram stain & culture  
- Blood culture (frequently ⊖)  
  
## Treatment  
  
- Antibiotics (typically MRSA and gram-negative coverage initially then narrowed based on culture data) ± surgery (decompressive laminectomy and debridement) for failure to improve on medical therapy. Emergent surgery for early s/s of cord compression (w/ vertebral osteo and epidural abscess).  
  
# 考古題  
## 專師  
  
  
  
## 內科  
  
